These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37273103)

  • 1. Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis.
    Zhu Q; Barnes CE; Mannes PZ; Latoche JD; Day KE; Nedrow JR; Novelli EM; Anderson CJ; Tavakoli S
    EJNMMI Res; 2023 Jun; 13(1):55. PubMed ID: 37273103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury.
    Haddad J; Latoche JD; Nigam S; Bellavia MC; Day KE; Zhu Q; Edwards WB; Anderson CJ; Tavakoli S
    J Nucl Med; 2021 Feb; 62(2):280-286. PubMed ID: 32680928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Imaging of VLA-4 in a New BRAF
    Bellavia MC; Nyiranshuti L; Latoche JD; Ho KV; Fecek RJ; Taylor JL; Day KE; Nigam S; Pun M; Gallazzi F; Edinger RS; Storkus WJ; Patel RB; Anderson CJ
    Mol Imaging Biol; 2022 Jun; 24(3):425-433. PubMed ID: 34694528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.
    Soodgupta D; Zhou H; Beaino W; Lu L; Rettig M; Snee M; Skeath J; DiPersio JF; Akers WJ; Laforest R; Anderson CJ; Tomasson MH; Shokeen M
    J Nucl Med; 2016 Apr; 57(4):640-5. PubMed ID: 26742713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
    Beaino W; Anderson CJ
    J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche.
    Shokeen M; Zheleznyak A; Wilson JM; Jiang M; Liu R; Ferdani R; Lam KS; Schwarz JK; Anderson CJ
    J Nucl Med; 2012 May; 53(5):779-86. PubMed ID: 22496586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.
    Beaino W; Nedrow JR; Anderson CJ
    Mol Pharm; 2015 Jun; 12(6):1929-38. PubMed ID: 25919487
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mahmutovic Persson I; Fransén Petterson N; Liu J; In 't Zandt R; Carvalho C; Örbom A; Olsson LE; von Wachenfeldt K
    Front Med (Lausanne); 2024; 11():1276420. PubMed ID: 38654839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron Emission Tomography Imaging of Macaques with Tuberculosis Identifies Temporal Changes in Granuloma Glucose Metabolism and Integrin α4β1-Expressing Immune Cells.
    Mattila JT; Beaino W; Maiello P; Coleman MT; White AG; Scanga CA; Flynn JL; Anderson CJ
    J Immunol; 2017 Jul; 199(2):806-815. PubMed ID: 28592427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evaluation of
    Roxin Á; Zhang C; Huh S; Lepage ML; Zhang Z; Lin KS; Bénard F; Perrin DM
    Nucl Med Biol; 2018 Jun; 61():11-20. PubMed ID: 29597141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Metal-Free DOTA-Conjugated
    Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
    Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1.
    Mannes PZ; Adams TS; Farsijani S; Barnes CE; Latoche JD; Day KE; Nedrow JR; Ahangari F; Kaminski N; Lee JS; Tavakoli S
    Sci Adv; 2024 Jun; 10(25):eadm9817. PubMed ID: 38896611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma.
    Soodgupta D; Hurchla MA; Jiang M; Zheleznyak A; Weilbaecher KN; Anderson CJ; Tomasson MH; Shokeen M
    PLoS One; 2013; 8(2):e55841. PubMed ID: 23409060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Al
    Gai Y; Yuan L; Sun L; Li H; Li M; Fang H; Altine B; Liu Q; Zhang Y; Zeng D; Lan X
    J Biol Inorg Chem; 2020 Feb; 25(1):99-108. PubMed ID: 31745667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
    Brody SL; Gunsten SP; Luehmann HP; Sultan DH; Hoelscher M; Heo GS; Pan J; Koenitzer JR; Lee EC; Huang T; Mpoy C; Guo S; Laforest R; Salter A; Russell TD; Shifren A; Combadiere C; Lavine KJ; Kreisel D; Humphreys BD; Rogers BE; Gierada DS; Byers DE; Gropler RJ; Chen DL; Atkinson JJ; Liu Y
    Am J Respir Crit Care Med; 2021 Jan; 203(1):78-89. PubMed ID: 32673071
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice.
    Perkins LA; Nyiranshuti L; Little-Ihrig L; Latoche JD; Day KE; Zhu Q; Tavakoli S; Sundd P; Novelli EM; Anderson CJ
    Blood Adv; 2020 Sep; 4(17):4102-4112. PubMed ID: 32882004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
    Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
    J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of a Collagen-Targeted PET Probe for Molecular Imaging of Pulmonary Fibrosis.
    Désogère P; Tapias LF; Rietz TA; Rotile N; Blasi F; Day H; Elliott J; Fuchs BC; Lanuti M; Caravan P
    J Nucl Med; 2017 Dec; 58(12):1991-1996. PubMed ID: 28611243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression.
    Isser S; Maurer A; Reischl G; Schaller M; Gonzalez-Menendez I; Quintanilla-Martinez L; Gawaz M; Pichler BJ; Beziere N
    J Nucl Med; 2023 Jun; 64(6):940-945. PubMed ID: 36702555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors.
    Jiang M; Ferdani R; Shokeen M; Anderson CJ
    Nucl Med Biol; 2013 Feb; 40(2):245-51. PubMed ID: 23265977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.